tiprankstipranks

Quest Diagnostics price target raised to $175 from $168 at Barclays

Barclays raised the firm’s price target on Quest Diagnostics (DGX) to $175 from $168 and keeps an Equal Weight rating on the shares. The company reported a solid quarter and guidance, which implies recent utilization and revenue trends remain stable, the analyst tells investors in a research note.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue